keyword
https://read.qxmd.com/read/36553526/microarray-analysis-reveals-changes-in-trna-derived-small-rnas-tsrnas-expression-in-mice-with-septic-cardiomyopathy
#1
JOURNAL ARTICLE
Ludong Yuan, Yuting Tang, Leijing Yin, Xiaofang Lin, Zhengyang Luo, Shuxin Wang, Jing Li, Pengfei Liang, Bimei Jiang
Background: tRNA-derived small RNAs (tsRNAs) as a novel non-coding RNA have been studied in many cardiovascular diseases, but the relationship between tsRNAs and septic cardiomyopathy has not been investigated. We sought to analyze changes of the expression profile of tsRNAs in septic cardiomyopathy and reveal an important role for tsRNAs. Methods: We constructed a sepsis model by cecal ligation and puncture (CLP) in mice, and microarray analysis was used to find differentially expressed tsRNAs. Quantitative real-time PCR was used to verify the expression of tsRNAs and the interference effect of angiogenin (ANG), a key nuclease producing tsRNAs...
November 30, 2022: Genes
https://read.qxmd.com/read/15467500/sorbents-in-the-treatment-of-renal-failure
#2
REVIEW
J F Winchester, J A Salsberg
Standard renal replacement therapy in acute renal failure (ARF) and end-stage renal disease (ESRD) is based on membrane technology. The transition from natural cellulosic membranes to synthetic membranes has not been associated with improvement in mortality rates. Modifications of dialysis with continuous arteriovenous hemofiltration and hemodiafiltration to remove middle molecular weight toxins, low molecular weight proteins and peptides (LMWP) and cytokines involved in inflammation appear to have reached their limits...
September 2004: Minerva Urologica e Nefrologica, the Italian Journal of Urology and Nephrology
https://read.qxmd.com/read/14732814/sorbents-in-acute-renal-failure-and-end-stage-renal-disease-middle-molecule-and-cytokine-removal
#3
JOURNAL ARTICLE
James F Winchester, Jeffrey Silberzweig, Claudio Ronco, Viktoria Kuntsevich, Daniel Levine, Tom Parker, John A Kellum, Jamie A Salsberg, Peter Quartararo, Nathan W Levin
Renal replacement therapy in acute renal failure (ARF) and chronic renal failure (end-stage renal disease; ESRD) has been based on the use of modifications of dialysis (continuous arteriovenous hemofiltration and hemodiafiltration) to remove middle-molecular-weight toxins, consisting of low-molecular-weight proteins and peptides (LMWP) and cytokines involved in inflammation. High-flux dialyzers are not efficient at removing LMWP, and for this reason, sorbents have been studied to augment or replace dialysis...
2004: Blood Purification
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.